Home > Income Statement > NEULAND LABORATORIES

NEULAND LABORATORIES
Revenue

    Back to Income Statement
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
COMMUNITY POLL
for NEULAND LABORATORIES
Please provide your vote to see the results

NEULAND LABORATORIES Last 5 Year Revenue History

[Consolidated]

Mar2024Mar2023Mar2022Mar2021Mar2020
Net Sales ₹1,559 Cr₹1,191 Cr₹951 Cr₹937 Cr₹763 Cr

What is the latest Revenue of NEULAND LABORATORIES ?

The latest Revenue ratio of NEULAND LABORATORIES is ₹1,559 Cr based on Mar2024 Consolidated results.
Year Revenue
Mar2024₹1,559 Cr
Mar2023₹1,191 Cr
Mar2022₹951 Cr
Mar2021₹937 Cr
Mar2020₹763 Cr

How is Revenue of NEULAND LABORATORIES Trending?

Years Revenue % Change
Mar2024 ₹1,559 Cr
30.84
Mar2023 ₹1,191 Cr
25.25
Mar2022 ₹951 Cr
1.51
Mar2021 ₹937 Cr
22.84
Mar2020 ₹763 Cr -

Compare Revenue of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹18,524.4 Cr 2.1% -1% 134.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,084.0 Cr -0% -4.6% 18.9% Stock Analytics
DIVIS LABORATORIES ₹162,384.0 Cr 8.8% 5.1% 64.4% Stock Analytics
CIPLA ₹118,853.0 Cr 2.4% -1.1% 0.8% Stock Analytics
DR REDDYS LABORATORIES ₹103,143.0 Cr 2.6% -9.9% -0.4% Stock Analytics
ZYDUS LIFESCIENCES ₹101,459.0 Cr 3.6% -0.1% 22.7% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

2.1%

-1%

134.2%

SENSEX

0.7%

-0.1%

8.8%


You may also like the below Video Courses